Switch to optionsXpress for advanced derivatives trading & earn 50 commission-free trades.
Advertisement
SureTrader Stock Hero Advertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Amarin Corp. PLC ADS (AMRN)

AMRN RSS Feed
Add AMRN Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Dancing in the dark, go seek, V63, investorfreak69, Biobillionair, HDGabor
Search This Board:
Last Post: 3/28/2015 2:41:37 PM - Followers: 316 - Board type: Free - Posts Today: 35

Amarin Home Page: http://www.amarincorp.com/

Vascepa (icosapent ethyl) Home Page: http://www.vascepa.com/savings.shtml

 

NASDAQ quote: http://www.nasdaq.com/symbol/amrn 

yahoo quote: http://finance.yahoo.com/q/h?s=AMRN 

AMRN company page on SA: http://seekingalpha.com/symbol/amrn?source=search_general&s=amrn


 

VASCEPA prescription spreadsheet: https://docs.google.com/spreadsheet/ccc?key=0AmTJU8mIVSebdGFUY253Y3BsTDBzbWRXSFVjbDZ0bHc#gid=12
Amarin Patent Spreadsheet :https://docs.google.com/spreadsheet/ccc?key=0Av_k_WaYce2IdDRKaWR1TmctcXVnMUhJQnlwbzEzeUE#gid=0

finviz page (headlines and basic stats); http://www.finviz.com/quote.ashx?t=AMRN&ty=c&ta=0&p=d

StreetInsider AMRN data page (headlines and analysts);  http://www.streetinsider.com/stock_lookup.php?LookUp=Get+Quote&q=amrn

 

Investor  Presentation (Apr'2013): http://files.shareholder.com/downloads/AMRN/2410758917x0x651653/CC47C992-CAF5-4A08-8DC6-F1DBF0AD5DB7/Amarin_Investor_Presentation_April_2013.pdf

Investor Presentation (Apr'2012):  http://www.amarincorp.com/downloads/investor-presentation.pdf

Amarin SEC filings: http://investor.amarincorp.com/sec.cfm

Vascepa FDA Orange Book page: http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=202057&Product_No=001&table1=OB_Rx
Vascepa CDER Medical / Clinical Review (July 25, 2012): http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202057Orig1s000MedR.pdf ;


FDA MAPP 5021.1 : http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ManualofPoliciesProcedures/UCM340273.pdf
(MANUAL OF POLICIES AND PROCEDURES, Naming of Drug Products Containing Salt Drug Substances)


~~~~~~~~~~~~~~~~~~~~~~
General:

Good & Bad Cholesterol - http://www.americanheart.org/presenter.jhtml?identifier=180

 

U.S. health system/CDC -  http://uk.reuters.com/article/2011/02/01/us-heart-usa-idUKTRE70N4JD20110201?feedType=RSS&feedName=healthNewsMolt

 

 

~~~~~~~~~~~~~~~~~~~~~~

General: 

The rationale for using EPA http://www.drsears.com/Portals/6/Documents/Understanding%20Eicosanoids.pdf 

 

Marine Trial hits all EndPoints - http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=533361

Marine Trial Conf Call (Nov '10):  - http://www.investorcalendar.com/IC/CEPage.asp?ID=162661

Transcript MARINE trial CC: http://files.shareholder.com/downloads/AMRN/1080589559x0x430674/E6D77DA6-F44C-405F-B479-9A5C31E7A6E3/AmarinCorporation112910_Transcript.pdf

Marine Trial Presentation - http://files.shareholder.com/downloads/AMRN/1080589559x0x423194/424D45B3-62CC-4A84-81D7-F5264EF82A11/MARINE_RESULTS_Nov_29_2010.pdf

Anchor Trial completes Enrollment - http://files.shareholder.com/downloads/AMRN/1080589559x0x428546/275b9676-c0cf-4bd0-a69b-e80e26433822/AMRN_News_2010_12_16_General_Releases.pdf

Anchor Trial hits all EndPoints - http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=569648

Anchor Trial Conf Call (Apr '11):  http://www.investorcalendar.com/IC/CEPage.asp?ID=164219

Additional Marine Trial Results:       http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=579260

 

Lovaza Label, etc

 

Excellent Blog Article featuring Lovaza data comparison - http://www.chasingthealpha.com/2010/11/amrn-look-at-tg-and-ldl-levels.html

 

http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-654_Omacor.cfm

 

http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021853_021654s016_omacor_toc.cfm

 

 

Various Trials, Statins/Lovaza etc:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813819/pdf/mayoclinproc_85_2_004.pdf

http://www.ncbi.nlm.nih.gov/pubmed/20877395

 

http://www.ncbi.nlm.nih.gov/pubmed/19002433

 

http://www.ncbi.nlm.nih.gov/pubmed/15250255

 

TriCor label, FIELD trial - http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021656s019lbl.pdf  

ACCORD trial - http://www.endocrinetoday.com/view.aspx?rid=61934 

                                                                    

Jelis Trial (Japan) - http://www.ccmdweb.org/dsl/middle.aspx?Slideid=2643&Catid=1043

transcript, ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE, 10/16/2013: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM376102.pdf
 




GOOGLE SPREADSHEET REGARDING PATENTS:
https://accounts.google.com/ServiceLogin?service=wise&passive=1209600&continue=https%3A%2F%2Fdocs.google.com%2Fspreadsheet%2Fccc%3Fkey%3D0Av_k_WaYce2IdDRKaWR1TmctcXVnMUhJQnlwbzEzeUE&followup=https%3A%2F%2Fdocs.google.com%2Fspreadsheet%2Fccc%3Fkey%3D0Av_k_WaYce2IdDRKaWR1TmctcXVnMUhJQnlwbzEzeUE&authuser=0#gid=0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMRN
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for AMRN
AMRN News: Should Investors Toss in the Towel on Amarin Corp Plc? 03/26/2015 12:02:02 PM
AMRN News: Shake Shack Shares Persist On The Hard To Borrow List 03/24/2015 02:57:13 AM
AMRN News: Biotech Stocks: 2 to Avoid, 1 to Buy 03/22/2015 12:56:03 PM
AMRN News: Amarin's Case Vs. FDA Will Garner Positive Attention 03/20/2015 05:44:35 PM
AMRN News: Amarin Argues In Court For Vascepa Exclusivity 03/18/2015 08:39:01 PM
PostSubject
#44150  Sticky Note These comments made by the CEO in the FishyFingers 03/12/15 09:07:30 PM
#30568  Sticky Note WRITE CONGRESS... WRITE THE FDA TODAY!!! go seek 07/11/14 07:31:47 PM
#4704  Sticky Note Everyone, Please get back on topic about AMRN, only. IH Admin [Linda] 04/22/13 09:21:30 AM
#46124   FDA requires all SE's listed in PI's that sts66 03/28/15 02:41:37 PM
#46123   The FDA, by hiding our comments were in sts66 03/28/15 02:29:36 PM
#46122   Don't recall the exact details, but the Pharmakon sts66 03/28/15 02:20:27 PM
#46121   ARNA doesn't use "API" to make Belviq - sts66 03/28/15 02:18:07 PM
#46120   AND if reports are true NCE was possibly rosemountbomber 03/28/15 02:03:42 PM
#46119   This is the biggest BS I heard from ggwpq 03/28/15 12:59:37 PM
#46118   Below is the answer I received from someone rafunrafun 03/28/15 12:42:46 PM
#46117   Like I am sure the FDA did not zmanindc 03/28/15 12:40:09 PM
#46116   Bio this is why they are posting comments zmanindc 03/28/15 12:36:23 PM
#46115   I came up with a conclusion, a long BioChica 03/28/15 11:38:46 AM
#46114   Tough shit, they brought this onto themselves! They BioChica 03/28/15 11:27:24 AM
#46113   Every company that goes through the FDA phases BioChica 03/28/15 11:23:43 AM
#46112   Ajax has relationship with Wax but cautioned that zumantu 03/28/15 11:16:15 AM
#46111   The whole concept of the NCE needs to ziploc_1 03/28/15 11:12:34 AM
#46110   zumantu-Thank you again for all of the articles couldbebetter 03/28/15 10:28:43 AM
#46109   Hello? Did you guys miss this? As JL zumantu 03/28/15 09:46:14 AM
#46108   Zum... IMO this paper, published a couple of days jessellivermore 03/28/15 09:45:20 AM
#46107   raf... Good question....I do not know the answer. jessellivermore 03/28/15 09:31:49 AM
#46106   Noone knows for certain when Vascepa revenues for couldbebetter 03/28/15 09:20:40 AM
#46105   Any idea why joint point is listed as rafunrafun 03/28/15 09:15:16 AM
#46104   I guess if anyone is in a position rafunrafun 03/28/15 09:12:49 AM
#46103   epe... EPA does not significantly lower LDL-C levels. By jessellivermore 03/28/15 09:12:40 AM
#46102   Clinical Trial DMC recommendations posted on Reg.gov, nothing Biobillionair 03/28/15 08:26:23 AM
#46101   Sipes Wife is an FDA insider... Biobillionair 03/28/15 08:02:05 AM
#46100   But keeping this behavior from fda could led stock_risk 03/28/15 07:46:34 AM
#46099   AD: The strongest evidence in support of nutrition zumantu 03/28/15 07:44:18 AM
#46098   Hamburg's last public address: http://www.modernhealthcare.com/article/20150327 rafunrafun 03/28/15 07:39:57 AM
#46097   subjects with any ‘high’ inflammation improved more on zumantu 03/28/15 07:33:41 AM
#46096   One more thing, why the AMRN-Eddingpharm is better HDGabor 03/28/15 07:32:13 AM
#46095   Unbelievable is damn right! It's beginning to be rafunrafun 03/28/15 07:30:49 AM
#46094   Where our society is heading, right JL? Bangtime 03/28/15 07:20:42 AM
#46093   Conclusions: A low serum EPA/AA ratio is significantly zumantu 03/28/15 07:15:22 AM
#46092   Fascinating. Thank you. Bangtime 03/28/15 07:14:01 AM
#46091   Otsuka sues FDA over exclusivity of Abilify alternatepatel 03/28/15 12:42:32 AM
#46090   Yes, the guy appears to have a Napoleonic go seek 03/28/15 12:26:50 AM
#46089   Not a bad idea, she saved millions of Biobillionair 03/27/15 10:06:01 PM
#46088   Whoever it is he posted that a long Biobillionair 03/27/15 10:04:27 PM
#46087   EPADI should send off Hamburg in style with zumantu 03/27/15 09:59:44 PM
#46086   Who that guy? He sounds like is zumantu 03/27/15 09:55:46 PM
#46085   Very impressive. rosemountbomber 03/27/15 09:21:44 PM
#46084   Zum Please keep posting science to EPADI CP like Biobillionair 03/27/15 08:54:38 PM
#46083   Happy last week of Hamburg! Everything has Biobillionair 03/27/15 08:44:19 PM
#46082   LMAO :>) BioChica 03/27/15 08:29:19 PM
#46081   :>} BioChica 03/27/15 08:25:54 PM
#46080   Sts66....Thanks for your reply concerning my arm issues......i epenephrine 03/27/15 07:51:03 PM
#46079   On 10-30-2014 REDUCEIT added "Safety/Efficacy Study" under study Biobillionair 03/27/15 07:43:19 PM
#46078   JL On 10-30-2014 REDUCEIT added "Safety/Efficacy Study" under study Biobillionair 03/27/15 07:34:59 PM
#46077   Jessie....I believe you to be right concerning my epenephrine 03/27/15 07:27:46 PM
#46076   C'mon..man jessellivermore 03/27/15 07:06:49 PM
#46075   I think it's relevant, won't be me BC. Biobillionair 03/27/15 07:02:45 PM
PostSubject